Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Shitara

Showing results (81-90 of 344) with videos related to

Pageof 35
Sort By:
Annals of Surgical Oncology|March 19, 2023
Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein-Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After SurgeryEigo Akimoto, Takeshi Kuwata, Kohei Shitara, et al.
The Oncologist|February 17, 2024
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic ReviewKohei Shitara, Alfred Falcone, Marwan G Fakih, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2007
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]Atsushi Ishiguro, Masaki Munakata, Kohei Shitara, et al.
International Journal of Clinical Oncology|May 12, 2011
A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumabAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Oncology|November 19, 2011
A retrospective comparison of docetaxel and paclitaxel for patients with advanced or recurrent esophageal cancer who previously received platinum-based chemotherapyAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Integrative Cancer Therapies|January 19, 2024
Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case SeriesMashiro Okunaka, Daisuke Kotani, Saori Mishima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 4, 2023
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experienceMashiro Okunaka, Akihito Kawazoe, Hitomi Nakamura, et al.
Case Reports in Oncology|February 25, 2011
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related ComplicationsKohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastasesAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Surgical Endoscopy|March 4, 2018
Clinicopathological features and endoscopic findings of HER2-positive gastric cancerYasuhiro Oono, Takeshi Kuwata, Kenji Takashima, et al.
Pageof 35

Showing results (81-90 of 344) with videos related to

Sort By:
Pageof 35
Annals of Surgical Oncology|March 19, 2023
Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein-Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After SurgeryEigo Akimoto, Takeshi Kuwata, Kohei Shitara, et al.
The Oncologist|February 17, 2024
Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic ReviewKohei Shitara, Alfred Falcone, Marwan G Fakih, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2007
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]Atsushi Ishiguro, Masaki Munakata, Kohei Shitara, et al.
International Journal of Clinical Oncology|May 12, 2011
A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumabAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Oncology|November 19, 2011
A retrospective comparison of docetaxel and paclitaxel for patients with advanced or recurrent esophageal cancer who previously received platinum-based chemotherapyAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Integrative Cancer Therapies|January 19, 2024
Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case SeriesMashiro Okunaka, Daisuke Kotani, Saori Mishima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 4, 2023
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experienceMashiro Okunaka, Akihito Kawazoe, Hitomi Nakamura, et al.
Case Reports in Oncology|February 25, 2011
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related ComplicationsKohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2011
FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastasesAyako Mizota, Kohei Shitara, Chihiro Kondo, et al.
Surgical Endoscopy|March 4, 2018
Clinicopathological features and endoscopic findings of HER2-positive gastric cancerYasuhiro Oono, Takeshi Kuwata, Kenji Takashima, et al.
Pageof 35